Aurinia Pharmaceuticals I... (AUPH)
NASDAQ: AUPH
· Real-Time Price · USD
8.62
0.59 (7.35%)
At close: Jun 26, 2025, 3:59 PM
8.49
-1.45%
After-hours: Jun 26, 2025, 04:08 PM EDT
7.35% (1D)
Bid | 8.49 |
Market Cap | 1.16B |
Revenue (ttm) | 247.29M |
Net Income (ttm) | 39.84M |
EPS (ttm) | 0.27 |
PE Ratio (ttm) | 31.91 |
Forward PE | 10.6 |
Analyst | Buy |
Ask | 8.88 |
Volume | 3,280,547 |
Avg. Volume (20D) | 1,220,908 |
Open | 8.05 |
Previous Close | 8.03 |
Day's Range | 7.99 - 8.80 |
52-Week Range | 5.20 - 10.67 |
Beta | 1.16 |
About AUPH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AUPH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AUPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Aurinia Pharmaceuticals Inc. is scheduled to release its earnings on Jul 31, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
+10.9%
Aurinia Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
9 months ago
+0.77%
Aurinia Pharmaceuticals shares are trading higher after the company announced a board restructuring consisting of seven members.

1 month ago · seekingalpha.com
Aurinia Pharmaceuticals Inc. (AUPH) Q1 2025 Earnings Call TranscriptAurinia Pharmaceuticals Inc. (NASDAQ:AUPH ) Q1 2025 Earnings Conference Call May 12, 2025 8:30 AM ET Company Participants Andrea Christopher - Corporate Communications and IR Peter Greenleaf - Preside...